President & CEO, Brainstorm Cell Therapeutics
Since September 2015, Mr. Lebovits also serves as the CEO of Brainstorm Cell Therapeutics on a permanent basis (previously, he served as Principal Executive Officer of Brainstorm from 2013 through 2014, on an interim basis). Mr. Lebovits controls ACC BioTech, which is focused on biotechnology. Additionally, he is involved in natural resources exploration projects around the world and has held senior positions in public and private companies in this field. Mr. Lebovits has also held senior positions for the worldwide Chabad Lubavitch organization, the largest Jewish organization in the world today and is a prominent figure in his community.
Presentation Title and Company Description
Emerging Therapeutics Showcase: NurOwn® Stem Cell Therapy for Treating ALS
BrainStorm Cell Therapeutics (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).